APEIRON Capital’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
APEIRON Capital's ABVX Position: Q3 2026 in Review
APEIRON Capital sold out of Abivax (ABVX) in Q3 2026, closing a stake of 130,600 shares — an estimated $17.4M sold.
APEIRON Capital first reported a position in ABVX in Q2 2026 and held it in 1 quarter. The position peaked at $17.4M in Q2 2026. 211 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- APEIRON Capital reported no remaining Abivax position as of Q3 2026 after selling out during the quarter.
- APEIRON Capital sold 130,600 Abivax shares in Q3 2026, an estimated $17.4M.
- APEIRON Capital first reported a position in Abivax in Q2 2026 and held it in 1 quarter.
- APEIRON Capital's Abivax position peaked at $17.4M in Q2 2026.
- 211 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on APEIRON Capital's 13F filing for Q3 2026, filed 4 Nov 2026.